Cargando…

UV-B-Bestrahlung in der COVID-​Therapie

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510531/
https://www.ncbi.nlm.nih.gov/pubmed/36186522
http://dx.doi.org/10.1007/s12688-022-00554-y
_version_ 1784797456706306048
collection PubMed
description
format Online
Article
Text
id pubmed-9510531
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-95105312022-09-26 UV-B-Bestrahlung in der COVID-​Therapie Rheuma Plus Aktuell Springer Vienna 2022-09-23 2022 /pmc/articles/PMC9510531/ /pubmed/36186522 http://dx.doi.org/10.1007/s12688-022-00554-y Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Aktuell
UV-B-Bestrahlung in der COVID-​Therapie
title UV-B-Bestrahlung in der COVID-​Therapie
title_full UV-B-Bestrahlung in der COVID-​Therapie
title_fullStr UV-B-Bestrahlung in der COVID-​Therapie
title_full_unstemmed UV-B-Bestrahlung in der COVID-​Therapie
title_short UV-B-Bestrahlung in der COVID-​Therapie
title_sort uv-b-bestrahlung in der covid-​therapie
topic Aktuell
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510531/
https://www.ncbi.nlm.nih.gov/pubmed/36186522
http://dx.doi.org/10.1007/s12688-022-00554-y